GlassScriptPhysician profile
Rajkamal Jit
NPI 1669453619
$15,245.59
in general payments reported to CMS, 2019-2025
45 companies · $3,033 in 2025
The $3,033 reported for 2025 was more than what 87% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,067 · 2020: $804 · 2021: $1,835 · 2022: $2,452 · 2023: $2,826 · 2024: $3,230 · 2025: $3,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,915 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,914.94 |
| Education | $173.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,657.39 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,209.55 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Janssen Biotech, INC. | $1,118.93 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $1,100.05 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Pfizer INC. | $836.13 | 2019-2025 | |
| Celgene Corporation | $746.65 | 2021-2024 | Zeposia |
| Genzyme Corporation | $743.79 | 2022-2025 | |
| Qol Medical, LLC | $385.45 | 2021-2025 | Sucraid, Sucraid |
| Ardelyx, INC. | $338.37 | 2022-2025 | Ibsrela |
| Ipsen Biopharmaceuticals, INC | $310.77 | 2024-2025 | Iqirvo, Bylvay |
| Intercept Pharmaceuticals, INC. | $296.07 | 2019-2023 | Ocaliva |
| Gilead Sciences, INC. | $224.61 | 2019-2024 | Epclusa |
| Daiichi Sankyo INC. | $219.72 | 2020-2024 | Injectafer |
| Lilly USA, LLC | $217.76 | 2024-2025 | Omvoh |
| Medtronic, INC. | $148.71 | 2021-2024 | Valleylab Ft10 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajkamal Jit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.